111 (NASDAQ:YI) Director Sells $17,610.00 in Stock

111, Inc. Sponsored ADR (NASDAQ:YI) Director Jian David Sun sold 70,440 shares of the business’s stock in a transaction that occurred on Wednesday, May 27th. The stock was sold at an average price of $0.25, for a total transaction of $17,610.00. Following the sale, the director owned 710,551 shares of the company’s stock, valued at approximately $177,637.75. This represents a 9.02% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. The sale was made to cover tax withholding obligations related to the vesting of equity awards.

Jian David Sun also recently made the following trade(s):

• On Tuesday, May 26th, Jian David Sun sold 29,280 shares of 111 stock. The stock was sold at an average price of $0.27, for a total transaction of $7,905.60.

111 Stock Down 0.4%

YI opened at $5.26 on Monday. 111, Inc. Sponsored ADR has a 52-week low of $2.48 and a 52-week high of $11.17. The company has a 50 day moving average of $6.26 and a two-hundred day moving average of $5.59. The company has a market cap of $46.24 million, a P/E ratio of -5.26 and a beta of 0.60.

Wall Street Analysts Forecast Growth

Separately, Weiss Ratings upgraded shares of 111 from a “sell (e+)” rating to a “sell (d-)” rating in a research note on Thursday, May 21st. One equities research analyst has rated the stock with a Sell rating, According to MarketBeat, the stock presently has an average rating of “Sell”.

111 Company Profile

111, Inc (NASDAQ: YI) is a leading online pharmacy e-commerce platform in China, operating under the brand 111.com. The company provides consumers with a comprehensive selection of pharmaceutical and healthcare products through its proprietary digital channels, including a website and mobile applications. By integrating online ordering, prescription management, and direct-to-consumer delivery, 111, Inc aims to streamline the purchase of medicines and health-related goods for customers nationwide.

111, Inc’s product portfolio encompasses prescription and over-the-counter drugs, nutritional supplements, vitamins, maternal and child care items, personal care products, and beauty goods.